Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) Director Joanna Horobin sold 8,500 shares of the stock in a transaction on Friday, June 7th. The shares were sold at an average price of $32.99, for a total value of $280,415.00. The sale was disclosed in a filing with the SEC, which is available through the […]
HC Wainwright reiterated their buy rating on shares of Kymera Therapeutics (NASDAQ:KYMR – Free Report) in a research note published on Friday morning, Benzinga reports. They currently have a $46.00 target price on the stock. Several other analysts have also recently weighed in on KYMR. JPMorgan Chase & Co. raised their target price on shares […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) has received a consensus rating of “Moderate Buy” from the twelve brokerages that are presently covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month price target among […]
Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) and Genus (OTCMKTS:GENSF – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk. Analyst Ratings This is a summary of current ratings […]
Kymera Therapeutics (NASDAQ:KYMR) Shares Down 5 5% dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.